Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism

被引:16
作者
Ganière, V
Feihl, F
Tagan, D
机构
[1] Hop Riviera, Dept Med Interne, CH-1800 Vevey, Switzerland
[2] CHUV, Univ Lausanne Hosp, Div Clin Pathophysiol, Lausanne, Switzerland
关键词
pulmonary embolism; pulmonary hypertension; sildenafil; thromboembolism;
D O I
10.1007/s00134-005-0058-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Sildenafil has a well established pulmonary vasodilatory effect, but has seldom been used in critically ill patients. We report a case of severe recurrent pulmonary embolism in which sildenafil was used as a rescue therapy. Results: After oral administration of 50 mg of sildenafil, cardiac index increased from 2.1 l/min/m(2) to 3.2 l/min/m(2); mean pulmonary artery pressure decreased from 56 mmHg to 46 mmHg, and pulmonary vascular resistance index decreased from 700 dynes/cm(-5)/m(2) to 425 dynes/cm(-5)/m(2), without reduction of arterial systemic pressure. Clinical condition also improved during the following days under treatment of 50 mg sildenafil three times daily. Conclusions: These observations should stimulate studies with sildenafil in the ICU setting. Sildenafil ICU and at any time. If its potential is confirmed, it may be a life- saving drug in some emergency situations caused by severe pulmonary hypertension.
引用
收藏
页码:452 / 454
页数:3
相关论文
共 15 条
[1]   Sildenafil can increase the response to inhaled nitric oxide [J].
Bigatello, LM ;
Hess, D ;
Dennehy, KC ;
Medoff, BD ;
Hurford, WE .
ANESTHESIOLOGY, 2000, 92 (06) :1827-1829
[2]  
DIAS CA, 2004, PULM PHARMACOL THER, V18, P181
[3]   Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension - A randomized prospective study [J].
Ghofrani, HA ;
Voswinckel, R ;
Reichenberger, F ;
Olschewski, H ;
Haredza, P ;
Karadas, B ;
Schermuly, RT ;
Weissmann, N ;
Seeger, W ;
Grimminger, F .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (07) :1488-1496
[4]   Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest Base Camp - A randomized, double-blind, placebo-controlled crossover trial [J].
Ghofrani, HA ;
Reichenberger, F ;
Kohstall, MG ;
Mrosek, EH ;
Seeger, T ;
Olschewski, H ;
Seeger, W ;
Grimminger, F .
ANNALS OF INTERNAL MEDICINE, 2004, 141 (03) :169-177
[5]   Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial [J].
Ghofrani, HA ;
Wiedemann, R ;
Rose, F ;
Schermuly, RT ;
Olschewski, H ;
Weissmann, N ;
Gunther, A ;
Walmrath, D ;
Seeger, W ;
Grimminger, F .
LANCET, 2002, 360 (9337) :895-900
[6]   Pulmonary embolism [J].
Goldhaber, SZ .
LANCET, 2004, 363 (9417) :1295-1305
[7]   Drug therapy: Treatment of pulmonary arterial hypertension [J].
Humbert, M ;
Sitbon, O ;
Simonneau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14) :1425-1436
[8]  
Lewis Gregory D, 2004, Cardiol Rev, V12, P188, DOI 10.1097/01.crd.0000122635.12743.57
[9]   Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects [J].
Mikhail, GW ;
Prasad, SK ;
Li, W ;
Rogers, P ;
Chester, AH ;
Bayne, S ;
Stephens, D ;
Khan, M ;
Gibbs, JSR ;
Evans, TW ;
Mitchell, A ;
Yacoub, MH ;
Gatzoulis, MA .
EUROPEAN HEART JOURNAL, 2004, 25 (05) :431-436
[10]   Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil? [J].
Ng, J ;
Finney, SJ ;
Shulman, R ;
Bellingan, GJ ;
Singer, M ;
Glynne, PA .
BRITISH JOURNAL OF ANAESTHESIA, 2005, 94 (06) :774-777